Integra Lifesciences Holdings (IART) Net Margin Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,379.00 |
| Dec 31, 2025 | -2,426.00 |
| Sep 30, 2025 | -1,008.00 |
| Jun 30, 2025 | -11,633.00 |
| Mar 31, 2025 | -920.00 |
| Dec 31, 2024 | 51.00 |
| Sep 30, 2024 | 447.00 |
| Jun 30, 2024 | -1,072.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -156.00 |
| Sep 30, 2023 | 146.00 |
| Jun 30, 2023 | -201.00 |
| Mar 31, 2023 | 328.00 |
| Dec 31, 2022 | 127.00 |
| Sep 30, 2022 | 1,183.00 |
| Jun 30, 2022 | 742.00 |
| Mar 31, 2022 | 626.00 |
| Jun 30, 2020 | 316.00 |
| Mar 31, 2020 | 424.00 |
| Dec 31, 2019 | 536.00 |
| Sep 30, 2019 | -770.00 |
| Jun 30, 2019 | 530.00 |
| Mar 31, 2019 | 790.00 |
| Dec 31, 2018 | -2,229.00 |
| Sep 30, 2018 | 1,786.00 |
| Jun 30, 2018 | 237.00 |
| Mar 31, 2018 | 614.00 |
| Dec 31, 2017 | 607.00 |
| Sep 30, 2017 | -516.00 |
| Jun 30, 2017 | -21.00 |
| Mar 31, 2017 | -94.00 |
| Jun 30, 2015 | -1,179.00 |
| Mar 31, 2015 | -1,047.00 |
| Dec 31, 2014 | 1,202.00 |
| Sep 30, 2014 | -796.00 |
| Jun 30, 2014 | -432.00 |